Literature DB >> 12749243

Fas-mediated apoptosis in acute alcoholic hepatitis.

Atsushi Tagami1, Hiroo Ohnishi, Hisataka Moriwaki, Martin Phillips, Robin D Hughes.   

Abstract

BACKGROUND/AIMS: The Fas-mediated apoptosis pathway has been implicated in liver diseases. The aim of the study was to investigate the role of this system in alcoholic hepatitis.
METHODOLOGY: The expression of Fas, Fas ligand, and intracellular signaling molecules for apoptosis were determined by immunoblot analysis in fresh frozen liver samples from 19 patients with alcoholic liver disease.
RESULTS: Fas and Fas ligand expression was significantly increased in the liver of patients with alcoholic hepatitis (n = 11) as compared with alcoholic liver disease patients without hepatitis (n = 8). Similarly, there were significant differences in the expression of FADD, ICE, and CPP32 in the liver between the two groups. There were significant positive correlations between the Fas ligand and the FADD, ICE, or CPP32 levels in the liver. The expression of Fas, Fas ligand, FADD, ICE, or CPP32 correlated with serum markers of hepatic injury. Plasma soluble Fas levels in patients with alcoholic hepatitis (median: 15.1 U/mL, range: 9.7-19.2 U/mL) were significantly higher than in normal controls (n = 9) (median: 2.8 U/mL, range: 1.9-3.7 U/mL; p < 0.001). There was a significant positive correlation between plasma soluble Fas levels and the hepatic expression of FADD in these patients.
CONCLUSIONS: These results indicate that Fas-mediated apoptosis may play an important role in alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749243

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

Review 1.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.

Authors:  Silvia Affò; Marlene Dominguez; Juan José Lozano; Pau Sancho-Bru; Daniel Rodrigo-Torres; Oriol Morales-Ibanez; Montserrat Moreno; Cristina Millán; Aurora Loaeza-del-Castillo; José Altamirano; Juan Carlos García-Pagán; Vicente Arroyo; Pere Ginès; Juan Caballería; Robert F Schwabe; Ramon Bataller
Journal:  Gut       Date:  2012-05-25       Impact factor: 23.059

Review 3.  Apoptosis as a mechanism for liver disease progression.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2010-10-19       Impact factor: 6.115

4.  Development of an accurate index for predicting outcomes of patients with acute liver failure.

Authors:  Anna Rutherford; Lindsay Y King; Linda S Hynan; Chetan Vedvyas; Wenyu Lin; William M Lee; Raymond T Chung
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

Review 5.  Immune cell-mediated liver injury.

Authors:  Nadia Corazza; Anastasia Badmann; Christoph Lauer
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

6.  A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis.

Authors:  Nan Jiang; Xusheng Zhang; Xiufen Zheng; Di Chen; Kingsun Siu; Hongmei Wang; Thomas E Ichim; Douglas Quan; Vivian McAlister; Guihua Chen; Wei-Ping Min
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

7.  Intestinal IL-17R Signaling Constrains IL-18-Driven Liver Inflammation by the Regulation of Microbiome-Derived Products.

Authors:  Patricia Castillo-Dela Cruz; Alanna G Wanek; Pawan Kumar; Xiaojing An; Waleed Elsegeiny; William Horne; Adam Fitch; Ansen H P Burr; Kathyayini P Gopalakrishna; Kong Chen; Barbara A Methé; Scott W Canna; Timothy W Hand; Jay K Kolls
Journal:  Cell Rep       Date:  2019-11-19       Impact factor: 9.423

Review 8.  Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Authors:  Yuanyuan Jin; Haixia Wang; Ke Yi; Shixian Lv; Hanze Hu; Mingqiang Li; Yu Tao
Journal:  Nanomicro Lett       Date:  2020-11-19

9.  Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.

Authors:  Fengjie Hao; Francisco Javier Cubero; Pierluigi Ramadori; Lijun Liao; Ute Haas; Daniela Lambertz; Roland Sonntag; Jörg-Martin Bangen; Nikolaus Gassler; Mareike Hoss; Konrad L Streetz; Johanna Reissing; Henning W Zimmermann; Christian Trautwein; Christian Liedtke; Yulia A Nevzorova
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

10.  CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells.

Authors:  Xin Hou; Xiaolei Hao; Meijuan Zheng; Congfei Xu; Jun Wang; Rongbin Zhou; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2016-04-04       Impact factor: 11.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.